Shkreli is accused of looting his former drug company Retrophin to pay off investors he allegedly defrauded at two hedge funds he ran. » Read More
By: Robert Frank
The Senate health-care bill would give the wealthy the biggest tax break in over a decade, according to an analysis. » Read More
By: Dylan Matthews
Here's one idea for universal coverage that doesn't require sudden massive tax increases, says Dylan Matthews. » Read More
By: Bertha Coombs
The large for-profit insurers and hospitals will find ways to grow, whether or not the GOP's health-reform bill is passed this summer. » Read More
Despite the drop in the use of painkillers by hurt workers, such medications remain commonly prescribed to them in many states.
Former employees of Insys Therapeutics were arrested for allegedly participating in kickback schemes involving doctors who prescribed the company's main drug, Subsys.
The expansion of Medicaid in many states has driven down the average amount of debt sent to collection agencies in many areas.
Bank of America CEO Brian Moynihan says employee wellness programs are a good investment. Here's how they're investing in employees—and saving money.
Shares of Walgreens and Rite Aid skyrocketed around 4 percent amid reports that the FTC is likely to approve Walgreens' acquisition of Rite Aid.
Mylan shares shed more than 5 percent after Wells Fargo Securities analysts said they were worried about the firm's pricing practices.
The "Fast Money" traders weighed election risks for biotech after Obama officially endorsed Hillary Clinton.
Several resorts in Mexico and Jamaica, where Zika is reported to be spreading actively, appear to have missed the memo about the dangers of the virus.
The accused fraudster blocked reporters from his Twitter feed as he toyed with starring in a new satirical musical.
Dr. Ken Davis also suggested that women may want to delay pregnancy because of the mosquito-born virus that's linked to birth defects.
Jack Ma's buyout of US-listed iKang Healthcare Group is a bitter pill for shareholders to swallow. Here's why.
Consumer electronics firm Withings has designed a set of scales that can check the health of your heart as well as your weight, the company claims.
Amgen said Wednesday that it has seen positive results for the chronic-migraine prevention drug it has been developing with Novartis.
Data from the Centers for Disease Control and Prevention show the obesity epidemic is getting worse, NBC News reports.
New rules would limit a person from using short-term health plans to no longer than three months.
The satirical show comes as Shkreli appears in court on criminal fraud charges, the New York Post says.
Sarepta Therapeutics said regulators have requested additional data from a study for its muscle-wasting treatment.
Shares of Alexion fell nearly 12 percent Monday after the pharmaceutical company said it missed its goal in a late-stage trial of the drug Solaris.
Enrollment on Obamacare exchanges has lagged original projections.
Valeant's CEO Joseph Papa says some of the firm's businesses are doing fine, but weak earnings and yet another downgrade sent the stock plunging.
Get the best of CNBC in your inbox